Multiple Sclerosis and Related Disorders, 2022
High-intensity resistance training in people with multiple sclerosis experiencing fatigue: A randomised controlled trial

Englund S., Piehl F., Kierkegaard M.

Journal of Molecular and Cellular Cardiology Plus, 2022
Serial measurements of protein and microRNA biomarkers to specify myocardial infarction subtypes

Schulte C., Singh B., Theofilatos K. et al.

Nature Cardiovascular Research, 2022
Identification of LTBP-2 as a plasma biomarker for right ventricular dysfunction in human pulmonary arterial hypertension

Boucherat O., Yokokawa T., Krishna V. et al.

Scientific Reports, 2022
A disturbed balance between blood complement protective factors (FH, ApoE) and common pathway effectors (C5a, TCC) in acute COVID-19 and during convalesce

Laudanski K., Okeke T., Siddiq K. et al.

American Heart Journal Plus: Cardiology Research and Practice, 2022
Higher plasma IL-6 and PTX3 are associated with worse survival in left heart failure with pulmonary hypertension

Helleberg S., Engel A., Ahmed S. et al.

Fluids and Barriers of the CNS, 2022
Posthemorrhagic hydrocephalus associates with elevated inflammation and CSF hypersecretion via activation of choroidal transporters

Lolansen S., Rostgaard N., Barbuskaite D. et al.

International Journal of Obesity, 2022
Heart failure in obesity: insights from proteomics in patients treated with or without weight-loss surgery

Karason K., Girerd N., Andersson-Asssarsson J. et al.

PROTEOMICS – Clinical Applications, 2022
Plasma biomarkers for systemic inflammation in COVID‐19 survivors

Zhao J., Schank M., Wang L. et al.

Journal of Investigative Dermatology, 2022
Comparison of the Inflammatory Circuits in Psoriasis Vulgaris, Non‒Pustular Palmoplantar Psoriasis, and Palmoplantar Pustular Psoriasis

Wang C., Haxhinasto S., Garcet S. et al.

Rheumatology, 2022
Plasma proteomics identifies CRTAC1 as a biomarker for osteoarthritis severity and progression

Szilagyi I., Vallerga C., Boer C. et al.

Diabetologia, 2022
Plasma prostasin: a novel risk marker for incidence of diabetes and cancer mortality

Bao X., Xu B., Muhammad I. et al.

Laboratory Investigation, 2022
High-throughput proteomics: a methodological mini-review

Cui M., Cheng C., Zhang L.

Biomedicines, 2022
A Targeted Proteomics Approach for Screening Serum Biomarkers Observed in the Early Stage of Type I Endometrial Cancer

Ura B., Capaci V., Aloisio M. et al.

Frontiers in Cardiovascular Medicine, 2022
Increased inflammatory markers in adult patients born with an atrial septal defect

Schram A., Sellmer A., Nyboe C. et al.

Nature Communications, 2022
Rare loss of function variants in the hepatokine gene INHBE protect from abdominal obesity

Deaton A., Dubey A., Ward L. et al.

Frontiers in Immunology, 2022
Plasma protein profiling reveals dynamic immunomodulatory changes in multiple sclerosis patients during pregnancy

Papapavlou Lingehed G., Hellberg S., Huang J. et al.

Frontiers in Immunology, 2022
Mobilization of systemic CCL4 following HIV pre-exposure prophylaxis in young men in Africa

Petkov S., Herrera C., Else L. et al.

Brain Communications, 2022
Neurofilament light increases over time in severe COVID-19 and is associated with delirium

Smeele P., Vermunt L., Blok S. et al.

Cardiovascular Research, 2022
Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation

Pol, T., Hijazi et al.

Cell Reports Medicine, 2022
Plaque characteristics and biomarkers predicting regression and progression of carotid atherosclerosis

Khan F., Gonçalves I., Shore A. et al.